Skip to main content
logo
Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.4200
-0.1002 (-19.26%)
Aug 10, 2026, 10:06 AM EDT - Market open

Ensysce Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4.715.075.212.232.523.53
Revenue Growth
-24.36%-2.75%133.58%-11.61%-28.54%-10.17%
Gross Profit
4.715.075.212.232.523.53
Operating Income
-11.84-10.24-6.73-10.72-24.22-19.87
Net Income
-15.52-10.18-7.99-10.63-25.09-29.89
Earnings Per Share
-3.35-3.98-11.45-70.40-2091.30-
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.754.313.51.123.1512.26
Total Debt
0.250.310.30.854.4317.21
Net Cash (Debt)
0.543.20.27-1.29-4.95
Net Cash Growth
-82.13%25.10%1090.16%---
Net Cash Per Share
0.131.574.591.78-107.24-

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-9.6-7.81-7.5-10.78-17.89-8.24
Capital Expenditures
--0.12----
Free Cash Flow
-9.6-7.93-7.5-10.78-17.89-8.24
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-251.40%-202.13%-129.18%-480.52%-959.91%-562.71%
Pretax Margin
-250.37%-200.85%-153.30%-476.40%-959.33%-825.38%
Profit Margin
-250.37%-200.85%-153.30%-476.40%-959.33%-825.38%
FCF Margin
-203.91%-156.51%-144.00%-483.30%-708.87%-233.41%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1.620.832.121.501.9132.80